🇺🇸 FDA
Pipeline program

The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in treatment of uncomplicated lower urinary tract infections.

SPh/01/2024

Phase 1 other active

Quick answer

The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in treatment of uncomplicated lower urinary tract infections. for Not applicable (submitted trial is a bioequivalence in healthy subjects) is a Phase 1 program (other) at Sciencepharma Sp. z o.o with 1 ClinicalTrials.gov record(s).

Program details

Company
Sciencepharma Sp. z o.o
Indication
Not applicable (submitted trial is a bioequivalence in healthy subjects)
Phase
Phase 1
Modality
other
Status
active

Clinical trials